Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Hoffman

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1995
A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chestE E Vokes, D J Haraf, L C Drinkard, et al.
Seminars in Oncology|August 1, 1995
Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancerP C Hoffman, S A Krauss, L C Drinkard, et al.
Seminars in Oncology|October 1, 1994
A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study designE E Vokes, L C Drinkard, B L Samuels, et al.
American Journal of Clinical Oncology|June 1, 1986
Pleural involvement in stage IIIM0 non-small-cell bronchogenic carcinoma. A need to differentiate subtypesK S Albain, P C Hoffman, A G Little, et al.
Journal of the National Cancer Institute|March 2, 1994
Phase I study of adozelesin administered by 24-hour continuous intravenous infusionG F Fleming, M J Ratain, S M O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancerG F Fleming, J W Kugler, P C Hoffman, et al.
Blood|November 1, 1987
Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lungM J Ratain, L S Kaminer, J D Bitran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancerJ D Winegarden, A M Mauer, G A Otterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignanciesG A Masters, D J Haraf, P C Hoffman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancerA M Mauer, R H Ansari, P C Hoffman, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Cancer Chemotherapy and Pharmacology|January 1, 1995
A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chestE E Vokes, D J Haraf, L C Drinkard, et al.
Seminars in Oncology|August 1, 1995
Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancerP C Hoffman, S A Krauss, L C Drinkard, et al.
Seminars in Oncology|October 1, 1994
A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study designE E Vokes, L C Drinkard, B L Samuels, et al.
American Journal of Clinical Oncology|June 1, 1986
Pleural involvement in stage IIIM0 non-small-cell bronchogenic carcinoma. A need to differentiate subtypesK S Albain, P C Hoffman, A G Little, et al.
Journal of the National Cancer Institute|March 2, 1994
Phase I study of adozelesin administered by 24-hour continuous intravenous infusionG F Fleming, M J Ratain, S M O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancerG F Fleming, J W Kugler, P C Hoffman, et al.
Blood|November 1, 1987
Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lungM J Ratain, L S Kaminer, J D Bitran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancerJ D Winegarden, A M Mauer, G A Otterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignanciesG A Masters, D J Haraf, P C Hoffman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancerA M Mauer, R H Ansari, P C Hoffman, et al.
Pageof 14